Numerous studies have shown that reduced adiponectin levels are associated with obesity, insulin resistance, dyslipidemia, hypertension, and an increased risk of type 2 diabetes and cardiovascular disease. This evidence concerns the gene ADIPOQ and cardiovascular disorder.